Spontaneous and inducible ventricular arrhythmias after myocardial infarction in mice.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 15081472)

Published in Cardiovasc Pathol on April 14, 2004

Authors

Tetsuo Betsuyaku1, Shigeto Kanno, Deborah L Lerner, Richard B Schuessler, Jeffrey E Saffitz, Kathryn A Yamada

Author Affiliations

1: Department of Medicine (Cardiovascular Division), Washington University School of Medicine, St. Louis, MO 63110, USA.

Articles by these authors

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol (2005) 5.80

A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med (2009) 4.54

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13

Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm (2004) 3.54

Transmural dispersion of repolarization in failing and nonfailing human ventricle. Circ Res (2010) 3.02

Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res (2006) 2.95

A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg (2004) 2.95

Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res (2002) 2.94

The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg (2003) 2.82

Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res (2004) 2.66

A national agenda for the future of pathology in personalized medicine: report of the proceedings of a meeting at the Banbury Conference Center on genome-era pathology, precision diagnostics, and preemptive care: a stakeholder summit. Am J Clin Pathol (2011) 2.58

Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation (2010) 2.57

Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res (2004) 2.50

Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci U S A (2004) 2.32

Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation (2005) 2.29

Electrical propagation in synthetic ventricular myocyte strands from germline connexin43 knockout mice. Circ Res (2004) 2.25

Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure. J Thorac Cardiovasc Surg (2008) 2.22

Optical mapping of the isolated coronary-perfused human sinus node. J Am Coll Cardiol (2010) 2.20

3D MRI-based multicomponent FSI models for atherosclerotic plaques. Ann Biomed Eng (2004) 2.17

c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. Circ Res (2002) 2.11

Targeted deletion of Kv4.2 eliminates I(to,f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ Res (2005) 2.09

Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels. J Physiol (2005) 2.05

Relative contributions of connexins 40 and 43 to atrial impulse propagation in synthetic strands of neonatal and fetal murine cardiomyocytes. Circ Res (2006) 1.97

Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles. J Physiol (2004) 1.96

A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2007) 1.91

Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm (2012) 1.91

Structural and functional evidence for discrete exit pathways that connect the canine sinoatrial node and atria. Circ Res (2009) 1.90

Local maximal stress hypothesis and computational plaque vulnerability index for atherosclerotic plaque assessment. Ann Biomed Eng (2005) 1.89

Atrial fibrillation propagates through gaps in ablation lines: implications for ablative treatment of atrial fibrillation. Heart Rhythm (2008) 1.87

Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart Rhythm (2010) 1.85

Microwave ablation for atrial fibrillation: dose-response curves in the cardioplegia-arrested and beating heart. Ann Thorac Surg (2006) 1.83

Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol (2004) 1.82

A call to action: training pathology residents in genomics and personalized medicine. Am J Clin Pathol (2010) 1.81

The cox-maze procedure for lone atrial fibrillation: a single-center experience over 2 decades. Circ Arrhythm Electrophysiol (2011) 1.79

Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm (2009) 1.78

Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation (2014) 1.76

Epicardial microwave ablation on the beating heart for atrial fibrillation: the dependency of lesion depth on cardiac output. J Thorac Cardiovasc Surg (2006) 1.73

The Cox maze IV procedure: predictors of late recurrence. J Thorac Cardiovasc Surg (2011) 1.73

Chronic transmural atrial ablation by using bipolar radiofrequency energy on the beating heart. J Thorac Cardiovasc Surg (2002) 1.63

Maintenance of myocyte volume homeostasis during stress by diazoxide is cardioprotective. Ann Thorac Surg (2007) 1.63

Surgical treatment of atrial fibrillation: predictors of late recurrence. J Thorac Cardiovasc Surg (2005) 1.61

A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails. J Am Coll Cardiol (2012) 1.59

Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation (2005) 1.59

Mechanoelectrical feedback as novel mechanism of cardiac electrical remodeling. Circulation (2007) 1.57

Matrix-protein-specific regulation of Cx43 expression in cardiac myocytes subjected to mechanical load. Circ Res (2005) 1.55

Protein kinase Cepsilon mediates salutary effects on electrical coupling induced by ischemic preconditioning. Heart Rhythm (2007) 1.54

A novel desmocollin-2 mutation reveals insights into the molecular link between desmosomes and gap junctions. Heart Rhythm (2011) 1.54

Conduction remodeling in human end-stage nonischemic left ventricular cardiomyopathy. Circulation (2012) 1.53

Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail (2012) 1.51

Differential calcium handling in two canine models of right ventricular pressure overload. J Surg Res (2012) 1.47

Heterogeneity and function of K(ATP) channels in canine hearts. Heart Rhythm (2013) 1.45

Map-guided surgery for atrial fibrillation. J Thorac Cardiovasc Surg (2005) 1.44

Impulse propagation in synthetic strands of neonatal cardiac myocytes with genetically reduced levels of connexin43. Circ Res (2003) 1.44

Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg (2007) 1.43

End stage of arrhythmogenic cardiomyopathy with severe involvement of the interventricular septum. Heart Rhythm (2012) 1.40

Quantifying effects of plaque structure and material properties on stress distributions in human atherosclerotic plaques using 3D FSI models. J Biomech Eng (2005) 1.38

Autocrine regulation of myocyte Cx43 expression by VEGF. Circ Res (2002) 1.34

Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts. J Mol Cell Cardiol (2011) 1.34

The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. J Interv Card Electrophysiol (2011) 1.30

Atrial tachyarrhythmias after the maze procedure: incidence and prognosis. Circulation (2004) 1.29

Role of activated CaMKII in abnormal calcium homeostasis and I(Na) remodeling after myocardial infarction: insights from mathematical modeling. J Mol Cell Cardiol (2008) 1.27

Physiological consequences of bipolar radiofrequency energy on the atria and pulmonary veins: a chronic animal study. Ann Thorac Surg (2003) 1.26

Efficacy and safety of right and left atrial ablations on the beating heart with irrigated bipolar radiofrequency energy: a long-term animal study. J Thorac Cardiovasc Surg (2006) 1.25

2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol (2011) 1.24

Echocardiographic evaluation of ventricular remodeling in a mouse model of myocardial infarction. J Am Soc Echocardiogr (2002) 1.24

Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study. Eur Heart J (2012) 1.24

Importance of geometry and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis. Circulation (2005) 1.19

Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant (2007) 1.18

Distinct pathways regulate expression of cardiac electrical and mechanical junction proteins in response to stretch. Circ Res (2005) 1.18

Evaluation of a novel cryoablation system: in vivo testing in a chronic porcine model. Innovations (Phila) (2013) 1.17

Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res (2003) 1.17

Cox-Maze IV results for patients with lone atrial fibrillation versus concomitant mitral disease. Ann Thorac Surg (2012) 1.13

Aortic valve replacement in octogenarians: risk factors for early and late mortality. Ann Thorac Surg (2007) 1.13

A prospective multicenter trial of bipolar radiofrequency ablation for atrial fibrillation: early results. Ann Thorac Surg (2004) 1.11

Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol (2011) 1.11

Remodeling of gap junctions in ischemic and nonischemic forms of heart disease. J Membr Biol (2007) 1.11

Complex interactions between the sinoatrial node and atrium during reentrant arrhythmias in the canine heart. Circulation (2010) 1.10

Evaluation of a novel cryoablation system: in vitro testing of heat capacity and freezing temperatures. Innovations (Phila) (2013) 1.09

Noninvasive electrocardiographic imaging (ECGI) of scar-related atypical atrial flutter. Heart Rhythm (2007) 1.09

Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. J Biol Chem (2004) 1.07

Hyperkalemic cardioplegia-induced myocyte swelling and contractile dysfunction: prevention by diazoxide. Ann Thorac Surg (2006) 1.07

Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J Am Coll Cardiol (2003) 1.06

The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. J Thorac Cardiovasc Surg (2011) 1.06